1. Home
  2. RCMT vs MCRB Comparison

RCMT vs MCRB Comparison

Compare RCMT & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$20.00

Market Cap

149.7M

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$15.44

Market Cap

140.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCMT
MCRB
Founded
1971
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.7M
140.7M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
RCMT
MCRB
Price
$20.00
$15.44
Analyst Decision
Strong Buy
Hold
Analyst Count
1
3
Target Price
$30.00
$14.33
AVG Volume (30 Days)
33.4K
49.3K
Earning Date
03-11-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.71
0.62
Revenue
$309,840,000.00
$351,000.00
Revenue This Year
$16.29
N/A
Revenue Next Year
$6.92
N/A
P/E Ratio
$11.76
$25.25
Revenue Growth
13.70
N/A
52 Week Low
$13.18
$6.53
52 Week High
$28.27
$29.98

Technical Indicators

Market Signals
Indicator
RCMT
MCRB
Relative Strength Index (RSI) 47.60 47.92
Support Level $19.65 $14.50
Resistance Level $21.06 $15.81
Average True Range (ATR) 0.69 0.88
MACD 0.01 0.06
Stochastic Oscillator 44.63 46.09

Price Performance

Historical Comparison
RCMT
MCRB

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: